Integrative analysis demonstrates Banxia Xiexin Decoction lowers inflammatory cytokines in ulcerative colitis, indicating gut health restoration.
Key Points
Treatment with Banxia Xiexin Decoction markedly reduces pro-inflammatory cytokines such as interleukin-1 beta and tumor necrosis factor-alpha in a murine model.
Comprehensive metabolomic and microbiome analysis identified shifts in gut microbiota, including increased Bifidobacterium and reduced Lachnospiraceae abundance.
The approach highlights improvements in intestinal barrier integrity and metabolic homeostasis linked to tryptophan metabolism modulation.
Results support the application of Banxia Xiexin Decoction for ulcerative colitis treatment by restoring gut microbiota and reducing inflammation.